Clinical trials
Recruiting Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 10 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| argenx | 4 |
| Takeda | 3 |
| Sanofi | 2 |
| Charles M Knudson | 1 |
| Dianthus Therapeutics | 1 |
| Grifols Therapeutics LLC | 1 |
| Immunovant Sciences GmbH | 1 |
| Janssen Research & Development, LLC | 1 |
| Kedrion S.p.A. | 1 |
| Kite, A Gilead Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 19 |
| Myasthenia Gravis | 4 |
| Multiple Sclerosis | 2 |
| Neuromyelitis Optica | 2 |
| Agammaglobulinemia | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Charcot-Marie-Tooth Disease | 1 |
| Glycogen Storage Disease Type II | 1 |
| Lambert-Eaton Myasthenic Syndrome | 1 |
| Mitochondrial Myopathies | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.